Androisoxazole
Clinical data | |
---|---|
Trade names | Neo-Ponden, Neo-Pondus |
Routes of administration | Oral |
Identifiers | |
Synonyms | 17α-Methyl-5α-androstano[3,2-c]isoxazol-17β-ol |
CAS Number | 360-66-7 Y |
PubChem (CID) | 9676 |
ChemSpider | 9295 Y |
Chemical and physical data | |
Formula | C21H31NO2 |
Molar mass | 329.476 g/mol |
3D model (Jmol) | Interactive image |
| |
| |
(verify) |
Androisoxazole (brand names Neo-Ponden, Neo-Pondus), also known as 17α-methyl-5α-androstano[3,2-c]isoxazol-17β-ol, is an orally active anabolic-androgenic steroid (AAS) and a 17α-alkylated derivative of dihydrotestosterone (DHT) that is marketed in Spain and Italy.[1][2][3][4] It is closely related to stanozolol, differing only in having an isoxazole instead of pyrazole ring fused to the A ring,[4] and is also related to furazabol, prostanozol, and danazol.
References
- ↑ Index Nominum 2000: International Drug Directory. Taylor & Francis. January 2000. pp. 63–. ISBN 978-3-88763-075-1.
- ↑ Charles D. Kochakian (6 December 2012). Anabolic-Androgenic Steroids. Springer Science & Business Media. pp. 384–. ISBN 978-3-642-66353-6.
- ↑ ANTONINI FM, VERDI G (October 1961). "[Preliminary results of experience with a new anabolic steroid, "androisoxazole," in the aged.]". Minerva Medica (in Italian). 52: 3437–41. PMID 13861810.
- 1 2 ARNOLD A, POTTS GO, BEYLER AL (December 1963). "RELATIVE ORAL ANABOLIC TO ANDROGENIC ACTIVITY RATIOS OF ANDROISOXAZOLE, ETHYLESTRENOL, METHYLANDROSTENOLISOXAZOLE AND TESTOSTERONE". Acta Endocrinologica. 44: 490–8. PMID 14082537.
AR |
| ||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|
GPRC6A |
| ||||||||||
See also: Estrogenics • Glucocorticoidics • Mineralocorticoidics • Progestogenics • Steroid hormone metabolism modulators • List of androgens/anabolic steroids |
This article is issued from Wikipedia - version of the 11/30/2016. The text is available under the Creative Commons Attribution/Share Alike but additional terms may apply for the media files.